{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:23:52Z","timestamp":1791206632460,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273812"],"award-info":[{"award-number":["82273812"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017526","name":"Sichuan Thousand Talents Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017526","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020207","name":"Health Commission of Sichuan Province","doi-asserted-by":"publisher","award":["21PJ106"],"award-info":[{"award-number":["21PJ106"]}],"id":[{"id":"10.13039\/501100020207","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009731","name":"Sichuan Provincial Youth Science and Technology Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009731","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ejmech.2024.116183","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T11:28:31Z","timestamp":1707132511000},"page":"116183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis"],"prefix":"10.1016","volume":"267","author":[{"given":"Xin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaozheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aiping","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1625-8682","authenticated-orcid":false,"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ejmech.2024.116183_bib1","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nrgastro.2010.100","article-title":"Hepatocellular carcinoma: a global view","volume":"7","author":"Yang","year":"2010","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116183_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5582\/bst.2022.01044","article-title":"Use of chemotherapy to treat hepatocellular carcinoma","volume":"16","author":"Hou","year":"2022","journal-title":"Biosci Trends"},{"key":"10.1016\/j.ejmech.2024.116183_bib3","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12935-018-0538-7","article-title":"Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight","volume":"18","author":"Lohitesh","year":"2018","journal-title":"Cancer Cell Int."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116183_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.14218\/JCTH.2017.00031","article-title":"Current and future treatment of hepatocellular carcinoma: an updated comprehensive review","volume":"6","author":"Daher","year":"2018","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.ejmech.2024.116183_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115784","article-title":"Suppressing metastasis via MEK\/ERK pathway and invoking mitochondrial apoptosis in triple-negative breast cancer","volume":"168","author":"Li","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2024.116183_bib6","article-title":"Bruceine a exerts antitumor effect against colon cancer by accumulating ROS and suppressing PI3K\/Akt pathway","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2024.116183_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106415","article-title":"Voacamine is a novel inhibitor of EGFR exerting oncogenic activity against colorectal cancer through the mitochondrial pathway","volume":"184","author":"Chen","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116183_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154015","article-title":"Activation of mitochondrial-associated apoptosis signaling pathway and inhibition of PI3K\/Akt\/mTOR signaling pathway by voacamine suppress breast cancer progression","volume":"99","author":"Zuo","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.ejmech.2024.116183_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105377","article-title":"Triptolide delivery: nanotechnology-based carrier systems to enhance efficacy and limit toxicity","volume":"165","author":"Ren","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejmech.2024.116183_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112081","article-title":"Celastrol: progresses in structure-modifications, structure-activity relationships, pharmacology and toxicology","volume":"189","author":"Hou","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2024.116183_bib11","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.canlet.2021.08.030","article-title":"Celastrol in cancer therapy: recent developments, challenges and prospects","volume":"521","author":"Lim","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ejmech.2024.116183_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114882","article-title":"Celastrol as an emerging anticancer agent: current status, challenges and therapeutic strategies","volume":"163","author":"Wang","year":"2023","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.ejmech.2024.116183_bib13","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1002\/med.21751","article-title":"Biosynthesis, total synthesis, structural modifications, bioactivity, and mechanism of action of the quinone-methide triterpenoid celastrol","volume":"41","author":"Lu","year":"2021","journal-title":"Med. Res. Rev."},{"issue":"19","key":"10.1016\/j.ejmech.2024.116183_bib14","doi-asserted-by":"crossref","first-page":"6355","DOI":"10.1039\/D1BM00639H","article-title":"Recent progress in nanotechnology-based drug carriers for celastrol delivery","volume":"9","author":"Guo","year":"2021","journal-title":"Biomater. Sci."},{"issue":"1","key":"10.1016\/j.ejmech.2024.116183_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1080\/21691401.2020.1725025","article-title":"Folic acid-modified celastrol nanoparticles: synthesis, characterization, anticancer activity in 2D and 3D breast cancer models","volume":"48","author":"Law","year":"2020","journal-title":"Artif. Cells, Nanomed. Biotechnol."},{"key":"10.1016\/j.ejmech.2024.116183_bib16","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.carbpol.2013.09.013","article-title":"Synthesis and characterization of biotin modified cholesteryl pullulan as a novel anticancer drug carrier","volume":"99","author":"Yang","year":"2014","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ejmech.2024.116183_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120628","article-title":"Curcumin-loaded liposomes with the hepatic and lysosomal dual-targeted effects for therapy of hepatocellular carcinoma","volume":"602","author":"Wang","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"45","key":"10.1016\/j.ejmech.2024.116183_bib18","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1039\/C5CC03003J","article-title":"Biotin-guided anticancer drug delivery with acidity-triggered drug release","volume":"51","author":"Park","year":"2015","journal-title":"Chem. Commun."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116183_bib19","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/sj.bjc.6690708","article-title":"The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells","volume":"81","author":"Trer\u00e8","year":"1999","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.ejmech.2024.116183_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1080\/10717544.2016.1225856","article-title":"Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma","volume":"24","author":"Pranatharthiharan","year":"2017","journal-title":"Drug Deliv."},{"issue":"3","key":"10.1016\/j.ejmech.2024.116183_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0168-3659(98)00124-2","article-title":"Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine","volume":"57","author":"Julyan","year":"1999","journal-title":"J. Contr. Release"},{"issue":"19","key":"10.1016\/j.ejmech.2024.116183_bib22","doi-asserted-by":"crossref","first-page":"14793","DOI":"10.1021\/acs.jmedchem.1c01365","article-title":"Development of asialoglycoprotein-mediated hepatocyte-targeting antitumor prodrugs triggered by glutathione","volume":"64","author":"Wang","year":"2021","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116183_bib23","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1039\/D0TB02071K","article-title":"A directed co-assembly of herbal small molecules into carrier-free nanodrugs for enhanced synergistic antitumor efficacy","volume":"9","author":"Wang","year":"2021","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.ejmech.2024.116183_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121598","article-title":"A small-molecule self-assembled nanodrug for combination therapy of photothermal-differentiation-chemotherapy of breast cancer stem cells","volume":"286","author":"Xie","year":"2022","journal-title":"Biomaterials"},{"issue":"13","key":"10.1016\/j.ejmech.2024.116183_bib25","doi-asserted-by":"crossref","first-page":"12176","DOI":"10.1021\/acsnano.3c00360","article-title":"Carrier-free nanodrug based on Co-assembly of methylprednisolone dimer and rutin for combined treatment of spinal cord injury","volume":"17","author":"Wang","year":"2023","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.ejmech.2024.116183_bib26","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2024.116183_bib27","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.ejmech.2024.116183_bib28","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/j.apsb.2021.12.007","article-title":"Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1","volume":"12","author":"Luo","year":"2022","journal-title":"Acta Pharm. Sin. B"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523424000631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:05:48Z","timestamp":1777529148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523424000631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S0223523424000631"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116183","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2024.116183","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116183"}}